Journal Watch · The EMBO Journal · 2026

Developmental priming of adult proteostasis and longevity by NuA4 complex activity in early life.

Together, these findings establish a chromatin-ER-lipid axis that developmentally primes adult proteostasis and suggest early-life interventions as a strategy to promote healthy aging and resilience to proteotoxic stress.

Wang Y, Xiong X, Zhang R et al.The EMBO Journal3 min readPharma relevance 30/100

DOI: 10.1038/s44318-026-00851-8PMID: 42463911Study type: preclinical (animal / model) study

TL;DR

Together, these findings establish a chromatin-ER-lipid axis that developmentally primes adult proteostasis and suggest early-life interventions as a strategy to promote healthy aging and resilience to proteotoxic stress.

Key findings

  • This UPR<sup>ER</sup> activation remodels endoplasmic reticulum (ER) morphology and reprograms lipid metabolism, driving selective oleic acid (OA) accumulation.
  • Crucially, this developmentally-installed OA reservoir confers lasting resilience against proteotoxic stress, an effect mimicked by OA supplementation.
  • Together, these findings establish a chromatin-ER-lipid axis that developmentally primes adult proteostasis and suggest early-life interventions as a strategy to promote healthy aging and resilience to proteotoxic stress.

What they did

Using C. elegans as a lifelong, genetically tractable AD model, we uncover a critical early-life window during which reducing TIP60/NuA4 acetyltransferase complex activity enduringly enhances proteostasis and extends lifespan. Mechanistically, NuA4 reduction depletes H4K16ac, triggering a compensatory, early-life-biased, XBP-1-mediated unfolded protein response (UPR<sup>ER</sup>).

Full abstract (original)

Background: Proteostasis collapse, a hallmark of aging and neurodegeneration like Alzheimer's disease (AD), causes irreversible damage in late life. Whether late-life proteostasis capacity is developmentally programmed remains unclear, as mechanistic studies requiring lifelong tracking and molecular manipulation are challenging or impossible in long-lived species.

What they did: Using C. elegans as a lifelong, genetically tractable AD model, we uncover a critical early-life window during which reducing TIP60/NuA4 acetyltransferase complex activity enduringly enhances proteostasis and extends lifespan. Mechanistically, NuA4 reduction depletes H4K16ac, triggering a compensatory, early-life-biased, XBP-1-mediated unfolded protein response (UPR<sup>ER</sup>).

Results & conclusions: This UPR<sup>ER</sup> activation remodels endoplasmic reticulum (ER) morphology and reprograms lipid metabolism, driving selective oleic acid (OA) accumulation. Crucially, this developmentally-installed OA reservoir confers lasting resilience against proteotoxic stress, an effect mimicked by OA supplementation. Together, these findings establish a chromatin-ER-lipid axis that developmentally primes adult proteostasis and suggest early-life interventions as a strategy to promote healthy aging and resilience to proteotoxic stress.

Abstract © the authors / The EMBO Journal (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s44318-026-00851-8 · PubMed 42463911.

Why it matters for pharma & biotech

  • Relevant to Biology & Life Sciences teams tracking The EMBO Journal for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this The EMBO Journal study find?

Together, these findings establish a chromatin-ER-lipid axis that developmentally primes adult proteostasis and suggest early-life interventions as a strategy to promote healthy aging and resilience to proteotoxic stress.

What type of study is this?

It is a preclinical (animal / model) study, published in The EMBO Journal in 2026. Using C.

Where can I read the original paper?

The original is at the publisher via DOI 10.1038/s44318-026-00851-8. PubMed ID: 42463911. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Wang Y, Xiong X, Zhang R et al.. Developmental priming of adult proteostasis and longevity by NuA4 complex activity in early life.. The EMBO Journal (2026). DOI: 10.1038/s44318-026-00851-8.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/developmental-priming-of-adult-proteostasis-and-longevity-by-nua4-comple-008518/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides